Main Office Address
The Johns Hopkins Hospital
The Johns Hopkins University
Medical College of Virginia
Triple Board Joint Training Program (Pediatrics, Psychiatry, Child Psychiatry) Mount SInai Hopsital, New York
|London School of Economics and Political Science|
New York University
Ecole des Hautes Etudes Commerciales de Paris - (Trium)
Dr. Findling is the Director of Child & Adolescent Psychiatry and a Vice Chair in the Department of Psychiatry at Johns Hopkins. He is also the Vice President of Psychiatric Services and Research at the Kennedy Krieger Institute.
Dr. Findling is working to foster and integrate the faculties, services and research opportunities at Johns Hopkins Hospital, Bayview Medical Center and the Kennedy Krieger Institute. Other professional interests include pediatric psychopharmacology and serious psychiatric disorders in the young.
Findling RL, Horwitz SM, Birmaher B, Kowatch RA, Fristad MA, Youngstrom EA, Frazier TW, Axelson D, Ryan N, Demeter CA, Depew J, Fields B, Gill MK, Deyling EA, Rowles BM, Arnold LE. Clinical characteristics of children receiving antipsychotic medication. Journal of Child & Adolescent Psychopharmacology, 21, 311-319, 2011
Axelson DA, Findling RL, Fristad MA, Kowatch RA, Youngstrom EA, Horwitz SM, Arnold LE, Frazier TW, Ryan N, Demeter C, Gill MK, Hauser-Harrington JC, Depew J, Kennedy SM, Gron BA, Rowles BM, Birmaher B. Examining the proposed Disruptive Mood Dysregulation Disorder Diagnosis in the Longitudinal Assessment of Manic Symptoms Study. Journal of Clinical Psychiatry, 73, 1342-1350, 2012
Findling RL, Youngstrom EA, McNamara NK, Stansbrey RJ, Wynbrandt JL, Adegbite C, Rowles BM, Demeter CA, Frazier TW, Calabrese JR. Double-blind, randomized, placebo-controlled long-term maintenance study of aripiprazole in children with bipolar disorder. Journal of Clinical Psychiatry, 73, 57-63, 2012
Findling RL, Correll CU, Nyilas M, Forbes RA, McQuade RD, Jin N, Ivanova S, Mankoski R, Carson WH, Carlson GA. Aripiprazole for the treatment of pediatric bipolar I disorder: a 30-week, randomized, placebo-controlled study. Bipolar Disorders, 15, 138-149, 2013
Findling RL, Kafantaris V, Pavuluri M, McNamara NK, Frazier JA, Sikich L, Kowatch R, Rowles BM, Clemons TE, Taylor-Zapata P. The post-acute effectiveness of lithium in pediatric bipolar I disorder. Journal of Child & Adolescent Psychopharmacology, 23, 80-90, 2013